News

The right-to-try gale is now blowing at full strength in the US and is likely to prove a straw in the wind that could become a haystack.

In this article, we will demonstrate a methodology that resulted in improving CRA performance.

Updated employee announcements, business news, awards, and recognition in the industry today.

Certified principal investigator certification as a predictor of major and critical protocol deviations in clinical trials.

Liquid biopsy, typically non-invasive blood-based tests for circulating tumor DNA and circulating tumor cells, has been long-hyped as a potential game-changer for cancer treatment.

In this article, we will discuss trends and challenges with medical monitoring clinical analytics, analyze the alignment of existing medical monitoring tools and technologies with ICH-E6 (R2) addendum guidelines, and discuss trends in medical monitoring insourcing and outsourcing models.

To manage the growing scope and complexity of global disclosure regulations and trial transparency initiatives, companies are advised to create a cross-functional clinical transparency committee.

Companies can utilize the following five tools to set themselves up for a successful trial.